AlphaYou
Overview
Smart money at a glance
Filings to Oct 10, 2026Net buying: insiders sold $0 and bought $102K on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- +$102K netNet buying
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, quarter ended Mar 31, 2026
- 1 added, 0 cutMore adding
Market overview
Fundamentals Oct 9- Open
- $125.97
- 52-wk high
- $144.35
- High
- $129.90
- 52-wk low
- $66.13
- Low
- $125.80
- Prev close
- $126.06
- Mkt cap
- $705.4M
- P/E
- 148.3x
- Volume
- 93.4K
- Fwd P/E
- 34.5x
- Beta
- 1.05
- Div yield
- 0.49%
- P/S
- 2.8x
- P/B
- 4.0x
- Profit margin
- +1.9%
- Op margin
- +11.7%
- ROE
- +2.7%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about MLAB filings
Are insiders buying or selling Mesa Laboratories Inc (MLAB) stock?
Net buying: insiders sold $0 and bought $102K of MLAB stock on the open market in the 90 days to Oct 10, 2026, according to SEC Form 4 filings. The largest was Tripeny, R Tony (Director), who bought $102K. The latest filing was on Aug 17, 2026.
Which members of Congress have traded MLAB recently?
None. No member of Congress disclosed a MLAB trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this MLAB smart-money data?
This summary uses filings available on Oct 10, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position and insiders have been net selling.
What funds are doing
Buys/Adds (1)
- AQ
AQR
$9.6M
added
What insiders are doing
Buys (2)
- KS
Kadia Siddhartha
$800K
private deal
- TR
Tripeny R Tony
$102K
bought
Sells (1)
- SJ
Sullivan John James
$800K
sold
How top traders are positioned
No tracked top-trader positions in MLAB right now.
Live Hyperliquid positioning - not every stock is covered
Earnings
Earnings came in 13.3% below what analysts expected.
Last report
Aug 4, 2026
Period ending
Jun 30, 2026
Earnings per share
$2.55 expected
Revenue
No reported revenue on record
Previous reports
All values in USD| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / estimate | Rev. surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Aug 4, 2026 | $2.21 / $2.55Alpha Vantage | -13.33% miss | Unavailable | Unavailable |
| Mar 31, 2026 | May 27, 2026 | $1.83 / $1.39Alpha Vantage | +31.47% beat | Unavailable | Unavailable |
| Dec 31, 2025 | Feb 3, 2026 | $1.76 / $1.47Alpha Vantage | +19.73% beat | Unavailable | Unavailable |
| Sep 30, 2025 | Nov 6, 2025 | $2.11 / $1.56Alpha Vantage | +35.26% beat | Unavailable | Unavailable |
| Jun 30, 2025 | Aug 5, 2025 | $1.88 / $2.16Alpha Vantage | -12.96% miss | Unavailable | Unavailable |
| Mar 31, 2025 | May 28, 2025 | $2.25 / $1.91Alpha Vantage | +17.80% beat | Unavailable | Unavailable |
| Dec 31, 2024 | Feb 4, 2025 | $0.79 / $1.51Alpha Vantage | -47.68% miss | Unavailable | Unavailable |
| Sep 30, 2024 | Nov 7, 2024 | $2.16 / $1.38Alpha Vantage | +56.52% beat | Unavailable | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue uses company releases and saved estimates.
Reports Nov 5, 2026, in 26 days
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $60.7M | $65.1M | $63.7M | $60.1M |
| Cost of what it sold | $23.4M | $23.3M | $17.1M | $21.1M |
| Gross profit | $37.3M | $41.8M | $46.6M | $39.0M |
| What it spent | ||||
| Research and development | $5.0M | $5.0M | $5.2M | $4.7M |
| Sales and admin | $17.8M | $18.8M | $24.1M | $17.4M |
| Other operating costs | $9.8M | $10.0M | $14.5M | $9.9M |
| Total operating expenses | $32.6M | $33.8M | $43.9M | $32.0M |
| What was left | ||||
| Operating profit | $4.7M | $8.0M | $2.7M | $7.0M |
| Interest on debt | $2.9M | $3.0M | $2.6M | $2.4M |
| Profit before tax | $2.0M | $4.6M | -$1.6M | $4.4M |
| Tax | -$477.0K | $966.0K | $2.5M | $1.5M |
| Net profit | $2.5M | $3.6M | -$4.1M | $2.8M |
| EBITDA | $10.7M | $13.3M | $4.2M | $12.4M |
Technicals
Price structure
This stock is in a strong uptrend.
Trend
Strong uptrend
80 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace